Posted inGenetics
Automated Mass Photometry Analysis Software
January 3, 2025 Refeyn has developed and launched a custom software platform that provides automated analysis of large mass photometry…
Posted inMedical Technology
FDA completes first phase of study into potential metal exposure from tampons
In September of last year, the FDA said it had begun exploring the potential health effects of various metals that…
Posted inBiotechnology
Revolutionizing Proteostasis: A Promising New Approach in Combating Neurodegenerative Disorders such as Alzheimer’s
Scientists are on the verge of a significant breakthrough in the battle against neurodegenerative diseases, particularly Alzheimer’s. Recent research conducted…
Posted inBiotechnology
Novel Strategies in Metastatic Breast Cancer: Harnessing Mini-Tumors from Circulating Cancer Cells
Researchers have made a significant breakthrough in the study of metastatic breast cancer by successfully cultivating tumor organoids from circulating…
Posted inBiotechnology
Loneliness Associated with Increased Risk of Heart Disease, Stroke, and Infection Vulnerability
Recent studies highlight a revolutionary connection between our social interactions and physical health, revealing that maintaining relationships with friends and…
Posted inBiotechnology
Revolutionary Insights into ‘Two-Faced’ Cancer Gene Challenge Traditional Disease Prediction Models
A groundbreaking study recently published in Nature Cancer has unveiled a surprising dual role played by the gene CDKN2A in…
Posted inBiotechnology
Transforming CO2 into Acetaldehyde: A Step Towards Sustainable Industrial Chemistry
Acetaldehyde is an essential chemical compound that plays a significant role in the production of numerous everyday products, from perfumes…
Posted inBiotechnology
Disparities in Agricultural Climate Policies: How Food Prices Are Impacted Unequally in Wealthy vs. Developing Nations
In a groundbreaking study published in Nature Food, researchers from the Potsdam Institute for Climate Impact Research (PIK) have uncovered…
Posted inBiotechnology
Investor pumps $3M into cash-strapped Cyclacel in return for CEO role
Investor David Lazar has come to the rescue of cash-strapped Cyclacel Pharmaceuticals, pumping $3 million into the biotech as well…
Posted inBiotechnology
Analysts predict M&A, IPO uptick in 2025 but don’t expect ‘floodgates to suddenly open’
Will 2025 be better? After another tough year, the answer to that question will shape the prospects of innumerable drug…